Vir Biotechnology (VIR) Other Non-Current Assets (2018 - 2026)

Vir Biotechnology's Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $7.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 10.89% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $7.0 million (up 10.89% YoY), while the FY2025 annual figure was $7.0 million, down 42.25% from the prior year.
• Other Non-Current Assets came in at $7.0 million for Q1 2026 at Vir Biotechnology, roughly flat from $7.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $13.2 million in Q2 2025 to a low of $6.3 million in Q1 2025.
• A 5-year average of $7.6 million and a median of $7.0 million in 2026 frame the typical range for Other Non-Current Assets.
• On a YoY basis, Other Non-Current Assets climbed as much as 107.16% in 2025 and fell as far as 42.25% in 2025.
• Vir Biotechnology's Other Non-Current Assets stood at $6.7 million in 2022, then decreased by 3.12% to $6.4 million in 2023, then surged by 86.99% to $12.1 million in 2024, then sank by 42.25% to $7.0 million in 2025, then slipped by 0.1% to $7.0 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $7.0 million, $7.0 million, and $7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison